SeqWright Genomic Services is a Contract Research Organization (CRO) specializing in providing a wide variety of genomic services, including the full-service nucleic acid technology CRO, molecular biology, to microarray, and next generation genomics. Founded in 1994 by John W. Belmont, M.D., Ph.D. and Richard Gibbs, Ph.D., Director of the Human Genome Sequencing Center, SeqWright was acquired by Clarient Diagnostic Services, Inc., a GE Healthcare Company in 2012.
SeqWright is CLIA certified and GLP compliant, which enables us to offer FDA and GLP-level services; a strength we have leveraged to provide Clinical Trial support services to the Pharmaceutical Industry and Genomics Services to the USDA. With almost 20 years of Genomics experience, we have earned a reputation for quality service, technical expertise, and a willingness to customize services to meet our client’s individual needs.
Customer-centered Commitment to Service Excellence
SeqWright’s mission is to facilitate and accelerate the research of our clients and help drive innovation within the industry. We believe that listening, understanding and working closely with our customers is essential to accomplishing this goal. We do not wish to be a faceless organization on the other side of computer screen or phone line. We believe in getting to know the people that work with us and finding new and improved ways of working with our clients to help them better accomplish their scientific goals.
What is a “SeqWright”?
The name “SeqWright” comes from “Seq” (sequence) and “Wright” (one who makes or constructs; a worker). It is a common misconception that our name is Seek-Right, Seq-Rite, or Seq-Write, although phonetically they sound correct.